US Pre-Market SEC Filings Roundup — May 13, 2026

13-05-2026

Lockheed Martin Corporation held its Annual Meeting of Stockholders on May 12, 2026, with 199,144,407 shares represented, achieving an 86.41% quorum out of 230,462,118 outstanding shares. Stockholders elected all nine director nominees, approved the advisory vote on named executive officer compensation, and ratified Ernst & Young LLP as independent auditors for 2026. However, the stockholder proposal requiring an independent board chairman was rejected, receiving only about 35% support.

• · Proposal 1 Director Election: Thomas J. Falk faced the highest opposition with 18,276,054 votes against out of approximately 164M votes cast.
• · Proposal 2 Say-on-Pay: 13,335,167 votes against.
• · Proposal 3 Auditor Ratification: No broker non-votes; 7,551,414 votes against.
• · Proposal 4 Independent Chairman: 103,555,181 votes against.
• · Meeting record date: March 2, 2026; Directors to serve until 2027 annual meeting.

13-05-2026

National Vision Holdings, Inc. reported Q1 2026 net revenue of $543.9 million, up 6.6% YoY, with comparable store sales growth of 4.4% (adjusted 4.5%), driven by higher average ticket and managed care strength but partially offset by lower self-pay traffic. Adjusted operating income rose 34.4% to $55.5 million with margin expansion to 10.2%, and net income increased to $31.2 million (5.7% margin) from $14.2 million (2.8%), while costs applicable to revenue grew 6.8% to 40.3% of revenue (up 10 bps) due to product mix. The company opened net new stores for 3.0% growth to 1,274 stores, expanded military presence by 20 stores via AAFES partnership, and reiterated FY2026 guidance including $2.033-$2.091 billion revenue.

• · Opened 8 new America’s Best stores, closed 3 America’s Best and 1 Military store in Q1.
• · No borrowings under $300.0M revolving credit facility (letters of credit $6.7M).
• · FY2026 guidance: New stores 30-35 (excl. 20 Military), Adj Diluted EPS $0.85-$1.09, CapEx $73M-$78M.

13-05-2026

DarioHealth Corp. reported Q1 2026 total revenues of $5,584, down 17% YoY from $6,752, driven by a 42% decline in services revenue to $2,826 despite a 47% increase in consumer hardware to $2,758. Operating loss improved 22% YoY to $7,309 from $9,409 due to lower operating expenses ($10,509 vs $13,291), resulting in a net loss of $8,249 versus $9,227 prior year, though cash and equivalents fell to $14,977 from $21,803 at Dec 31, 2025 amid $6,025 operating cash burn. The company noted recurring losses, an accumulated deficit of $460,327, and dependency on additional funding to sustain operations.

• · Net cash used in operating activities was $6,025 in Q1 2026, improved from $6,673 in Q1 2025.
• · Warrant liability decreased to $23 from $1,466 QoQ.
• · Basic and diluted loss per share improved to $1.25 from $2.87 YoY.
• · Going concern uncertainty due to recurring losses and need for additional funding.

13-05-2026

A&B Aerospace, Inc., the target in a potential sale transaction referenced in PMGC Holdings Inc.'s (ELAB) 8-K filing, reported nine-month revenue growth of 12.8% YoY to $3,607,404 and swung to net income of $343,903 from a prior-year loss of $108,061, with operating cash flow rising to $349,252 from $134,235. Three-month revenue surged 25.5% YoY to $1,274,503, driving net income of $123,492 versus a $313,582 loss. However, the nine-month period included a $695,763 inventory impairment charge, and property and equipment net declined to $463,772 from $543,627.

• · Net working capital of $1,447,000 as of Feb 28, 2026 with current ratio of 3.9:1
• · Investments at fair value $344,336 as of Feb 28, 2026 versus $178,657 at May 31, 2025
• · Total liabilities decreased to $497,497 from $520,329
• · Stockholders’ equity $1,911,116 as of Feb 28, 2026

13-05-2026

NEUMEIER POMA INVESTMENT COUNSEL LLC filed its quarterly 13F-HR report disclosing 41 equity holdings with a total market value of $1,213,284,716 as of March 31, 2026. The portfolio is concentrated in small- to mid-cap stocks across industrials, technology, and sustainable infrastructure, with top positions including Hannon Armstrong Sustainable Infrastructure Capital Inc. ($56,291,592), OSI Systems Inc. ($50,826,579), Fabrinet ($49,991,864), TTM Technologies Inc. ($48,685,645), and Silicon Motion Technology Corp. ($48,081,231). No period-over-period changes are disclosed in this filing.

• · Filing date: May 13, 2026
• · Report period end: March 31, 2026
• · Filer address: 26435 Carmel Rancho Boulevard, Suite 200, Carmel, CA 93923
• · SEC file number: 028-06534

13-05-2026

SS Innovations International, Inc. reported robust Q1 FY2026 revenue growth of 117% YoY to $11,101,366, driven by system sales (+113% to $9,575,370), instruments (+141% to $1,151,228), and warranty sales (+192% to $357,686), with gross profit surging 390% to $5,327,221. However, operating expenses increased 28% to $8,965,978, leading to a narrowed but still significant net loss of $3,582,571 (vs. $5,681,353 YoY) and comprehensive loss of $5,133,048; lease income declined slightly 7% to $17,082. The balance sheet strengthened with total assets at $90,546,889 (up 22% QoQ), cash at $15,979,714 (up 398% QoQ), and stockholders' equity at $54,523,413 following $18,446,498 net PIPE proceeds.

• · Net cash used in operating activities improved to $2,311,936 from $6,103,374 YoY.
• · Stock compensation expense rose to $3,144,315 from $2,379,212 YoY.
• · Foreign currency translation loss of $1,557,111 contributed to comprehensive loss.
• · Weighted average basic shares: 196,007,956 (Q1 2026) vs. 178,836,342 (Q1 2025).

13-05-2026

Regis Corporation reported Q3 FY2026 consolidated revenue of $52.4 million, down $4.6 million or 8.1% YoY from $57.0 million, primarily due to lower franchise royalties, fees, and rental income despite consolidated same-store sales growth of 2.6% (Supercuts +5.0%, company-owned +9.6%). Operating income improved to $5.7 million from $5.0 million, net income to $0.7 million from $0.3 million, and adjusted EBITDA to $7.7 million from $7.1 million. Year-to-date FY2026 revenue rose to $168.5 million from $149.7 million driven by the Alline acquisition, but franchise revenue declined 13.0% to $110.0 million and YTD net income fell to $2.5 million from $7.0 million due to absence of prior-year discontinued operations income.

• · Alline acquisition completed December 19, 2024
• · Franchise salons decreased to 3,497 from 3,776 YoY
• · Company-owned salons decreased to 273 from 311 YoY
• · Available total liquidity of $31.9 million as of Q3 FY2026 end
• · Sixth consecutive quarter of positive cash from operations
• · YTD FY2026 cash from operations $8.9 million, up $1.9 million YoY

13-05-2026

Expensify, Inc. announced the commencement of a modified Dutch auction tender offer to purchase up to $25,000,000 of its Class A common stock at a price per share between $0.98 and $1.20. The offer is not conditioned on any minimum number of shares tendered or financing and is scheduled to expire at midnight New York City time on June 10, 2026, unless extended. Tender offer documents and terms have been filed with the SEC, with the press release attached as Exhibit 99.1.

• · Tender offer filed under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits)
• · Class A common stock trades on Nasdaq under symbol EXFY

13-05-2026

The Cigna Group reaffirmed its full year 2026 outlook for consolidated adjusted income from operations of at least $30.35 per share during upcoming investor and analyst meetings. This projection aligns with guidance previously issued on April 30, 2026, via press release and conference call. The filing includes standard forward-looking statement disclaimers and risk factors but no updates or changes to the outlook.

• · Outlook previously discussed in press release dated April 30, 2026, and related investor conference call transcript available at www.thecignagroup.com
• · Adjusted income from operations excludes net investment gains/losses, amortization of acquired intangible assets, special items, and certain joint venture results

13-05-2026

Innospec Inc. held its 2026 Annual Meeting of Stockholders on May 8, 2026, with 22,661,185 shares present or by proxy, representing 91% of the 24,890,467 outstanding shares entitled to vote. Stockholders re-elected Class I directors Elizabeth K. Arnold and Claudia P. Poccia, approved the advisory vote on executive compensation, and ratified the appointment of the independent registered public accounting firm for 2026, with all proposals receiving strong support and no significant opposition noted.

• · Record date for Annual Meeting: March 13, 2026
• · Broker non-votes consistent at 1,598,678 across director elections and executive compensation proposal

13-05-2026

Equifax Inc. held its 2026 Annual Meeting of Shareholders on May 7, 2026, with 112,862,429 shares represented in person or by proxy. Shareholders elected all ten director nominees, though some faced notable opposition such as Mark L. Feidler (7,236,445 against) and Robert D. Marcus (7,548,239 against), alongside 5,351,539 broker non-votes. Key proposals passed including advisory approval of named executive officer compensation (90,426,432 for), ratification of Ernst & Young LLP as auditors (107,056,475 for), and lowering the special meeting ownership threshold to 25% (98,693,741 for), while the shareholder proposal to lower it to 10% failed decisively (38,908,801 for vs. 68,336,404 against).

• · Advisory vote on lowering special meeting threshold to 25%: 98,693,741 for, 7,166,821 against, 1,650,328 abstentions.
• · Ratification of auditors had 5,741,059 against and 64,895 abstentions.
• · All director elections had broker non-votes of 5,351,539 shares.

13-05-2026

Aquaron Acquisition Corp. entered into Amendment No. 4 to its Investment Management Trust Agreement with Continental Stock Transfer & Trust Company, dated May 7, 2026, extending the Trust Account liquidation deadline from May 6, 2024 (as previously amended) to the later of May 6, 2027 or as provided in the Company's Amended and Restated Certificate of Incorporation. The Trust Account holds $54,984,377 from IPO and Private Placement Units proceeds. The amendment was approved by the requisite stockholder vote holding at least 50% of Common Stock.

• · Previous amendments to Trust Agreement: June 29, 2023 (No. 1), April 30, 2024 (No. 2), May 6, 2025 (No. 3)
• · Original Trust Agreement dated October 3, 2022
• · Stockholder approval threshold: affirmative vote of holders of at least 50% of Common Stock present or represented

13-05-2026

Starlink AI Acquisition Corporation, a Cayman Islands-based blank check company (SPAC), priced its initial public offering of 10,000,000 units at $10.00 per unit, raising $100 Million. Units are expected to begin trading on the NYSE under ticker OTAIU on May 8, 2026, with closing anticipated on May 11, 2026, subject to customary conditions. A.G.P./Alliance Global Partners serves as the sole book-running manager and has a 45-day option to purchase up to 1,500,000 additional units for over-allotments.

• · Each unit consists of one ordinary share and one right to receive one-fourth of one ordinary share upon consummation of an initial business combination.
• · Registration statement on Form S-1 (File No. 333-292878) declared effective by SEC on May 7, 2026.
• · Post-separation trading: ordinary shares as OTAI, rights as OTAIR on NYSE.
• · Company targets merger, share exchange, asset acquisition, or similar business combination without industry limitation.

13-05-2026

Anteris Technologies Global Corp. appointed Ms. Susan Knight as a Class I Director (term expiring at 2028 annual meeting) and Mr. Stephen Denaro as a Class II Director (term expiring at 2026 annual meeting) effective May 11, 2026 (May 12 in Australia), with Ms. Knight joining the Audit and Risk Committee. Ms. Knight brings extensive CFO and board experience from Surmodics, Inc., MTS Systems Corporation, and Honeywell, Inc., while Mr. Denaro rejoins with deep company knowledge. Compensation includes an initial $250,000 RSU grant for Ms. Knight, $125,000 annual RSUs for both, and AUD $57,645 annual fee for Mr. Denaro's subsidiary secretary roles.

• · Indemnification agreements entered with Ms. Knight and Mr. Denaro effective May 11, 2026.
• · Ms. Knight's RSU grant subject to stockholder approval per Australian Securities Exchange rules.
• · Mr. Denaro serves as Company Secretary for certain Australian subsidiary entities.

13-05-2026

Azitra reported Q1 2026 net loss of $3.9 million, widening from $3.1 million YoY due to increased R&D expenses ($1.6 million vs. $1.3 million) and G&A expenses ($2.4 million vs. $1.9 million), reflecting higher operational spending. Positively, cash and cash equivalents rose to $10.1 million from $2.1 million at year-end 2025 following a private placement of up to $10.5 million (plus $20.9 million warrants), and the company advanced its pipeline with MD Anderson added to the ATR-04 Phase 1/2 trial, a new U.S. patent for ATR-12, and launch of ATR-COSF cosmeceutical initiative. Topline data for ATR-12 and ATR-04 trials expected in H2 2026.

• · Net loss per share improved to $(0.25) from $(1.55) YoY due to increased shares outstanding (15,517,992 vs 1,977,670).
• · 50% of patients enrolled in ATR-12 Phase 1b trial as of June 2025, with generally safe and well-tolerated profile to date.
• · First patient dosed in ATR-04 Phase 1/2 trial in Q3 2025.
• · ATR-COSF repeat application study results expected mid-2026; human study planned Q3 2026.
• · New U.S. patent issued covering ATR-12.

13-05-2026

News Corporation filed an 8-K on May 13, 2026, reporting on disclosures made to the Australian Securities Exchange (ASX) regarding its stock repurchase program, which authorizes up to $1 billion in aggregate repurchases of Class A common stock (NWSA) and Class B common stock (NWS). The disclosures for specific dates are attached as Exhibits 99.1 and 99.2. No specific repurchase transactions are detailed in the filing, which includes forward-looking statements subject to market conditions and risks.

• · Date of earliest event reported: May 12, 2026
• · Registrant details: Delaware incorporation, Commission File Number 001-35769, IRS Employer Identification No. 46-2950970
• · Principal executive offices: 1211 Avenue of the Americas, New York, New York 10036, telephone (212) 416-3400

13-05-2026

Farmers & Merchants Bancorp held its Annual Meeting of Stockholders on May 11, 2026, with a quorum of 397,812 shares present, representing 57.40% of shares outstanding. All seven director nominees were elected with strong support, receiving between 386,334 and 394,409 votes for and minimal withheld votes ranging from 3,403 to 11,478. Stockholders approved executive compensation on a non-binding advisory basis with 91.04% in favor, 3.05% against, and 5.91% abstaining.

13-05-2026

Paysign, Inc. held its annual meeting of stockholders on May 8, 2026, electing all seven director nominees to the Board with overwhelming majorities, ranging from 34,852,034 'For' votes for Dennis L. Triplett to 37,507,596 for Joan M. Herman, amid 595,123 to 3,031,671 withheld votes and 641,671 broker non-votes. Proposal 2 to ratify Baker Tilly US, LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, passed with 38,429,068 'For', only 279 'Against', and 96,029 'Abstain'. No proposals failed, indicating strong shareholder approval.

• · Proxy statement filed with SEC on March 26, 2026.
• · Meeting results reported in 8-K filed May 13, 2026, for event on May 8, 2026.
• · Highest withheld votes for Dennis L. Triplett at 3,031,671 shares.

13-05-2026

Tempus AI, Inc. (TEM) announced a proposed private placement of $350.0 million aggregate principal amount of Convertible Senior Notes due 2032, with an option for initial purchasers to buy up to an additional $52.5 million, to repay in full $307.7 million of outstanding loans under senior secured credit facilities plus accrued interest and fees, thereby reducing interest expense and enhancing financial flexibility. Net proceeds will also fund capped call transactions to reduce potential dilution upon conversion and support general corporate purposes including acquisitions and working capital. While the offering aims to optimize capital structure, related hedging activities by counterparties may impact the market price of Class A common stock or Notes.

• · Notes to be offered pursuant to Rule 144A to qualified institutional buyers.
• · Notes mature on May 15, 2032; interest payable semiannually in arrears.
• · Upon conversion, Tempus may settle in cash, Class A common stock (par value $0.0001), or combination.
• · Capped call transactions to cover shares underlying the Notes, subject to adjustments.
• · Announcement date: May 7, 2026; SEC filing date: May 13, 2026.

13-05-2026

West Enclave Merger Corp., a Cayman Islands-based SPAC, consummated its IPO on May 1, 2026, selling 10,000,000 units at $10.00 per unit for gross proceeds of $100,000,000, alongside a private placement of 425,000 units generating $4,250,000, with $101,000,000 placed in trust. Underwriters exercised the full over-allotment option on May 4, 2026, purchasing 1,500,000 additional units for $15,000,000, closing on May 6, 2026, with a simultaneous private placement of $412,500. Beginning May 13, 2026, holders may separate units to trade ordinary shares (WENC) and rights (WENC RT) separately on the NYSE.

• · Audited balance sheet as of May 1, 2026, filed as Exhibit 99.1.
• · Press release on over-allotment closing filed as Exhibit 99.2 (May 6, 2026).
• · Press release on unit separation filed as Exhibit 99.3 (May 8, 2026).
• · Over-allotment option granted for 45 days from IPO.

13-05-2026

GP-Act III Acquisition Corp. entered into Non-Redemption Agreements on May 11, 2026, with investors holding 8,074,387 Class A ordinary shares, committing them not to redeem shares and to vote in favor of extending the business combination deadline from May 13, 2026, to November 13, 2026 (Extension Amendment Proposal) and amending the trust agreement accordingly (Trust Amendment Proposal). In exchange, the Sponsor (GP-Act III Sponsor LLC) will transfer 403,720 Class A ordinary shares to these investors post-business combination closing. These agreements aim to boost approval chances at the upcoming extraordinary general meeting and preserve more funds in the trust account.

• · Proxy statement filed with SEC on March 30, 2026; record date for meeting March 24, 2026
• · Investment Management Trust Agreement dated May 8, 2024
• · Non-Redemption Agreements terminate upon failure of proposals approval, fulfillment of obligations, liquidation, mutual agreement, or investor breach
• · Company may enter additional similar non-redemption agreements

13-05-2026

GCI Liberty, Inc. filed an 8-K on May 13, 2026, disclosing amendments to its Articles of Incorporation under Items 3.03, 5.03, 5.07, 7.01, and 9.01, with Exhibit 3.1 providing the Certificate of Amendment filed with the Nevada Secretary of State. The amendments were approved by stockholders holding shares entitling them to at least a majority of the voting power (or greater as required). Specific changes, such as to entity name or authorized shares, are indicated via form options but not detailed in the provided content.

• · Applicable NRS sections: 78.380, 78.385, 78.390, 78.403
• · Certificate type: Amendment to Articles of Incorporation (after issuance of stock)

13-05-2026

At Liberty Broadband Corporation’s annual stockholder meeting on May 11, 2026, shareholders re-elected John C. Malone, Gregg L. Engles, and John E. Welsh III as Class III directors until the 2029 annual meeting. KPMG LLP was ratified as independent auditors for the fiscal year ending December 31, 2026, with overwhelming support (19,875,951 votes for vs. 74,821 against and 98,965 abstentions). While all proposals passed, significant votes were withheld for directors, notably 5,865,917 for John E. Welsh III.

• · Meeting held on May 11, 2026; filed on May 13, 2026 (report date May 11, 2026)
• · Directors to serve until 2029 annual meeting or earlier resignation/removal

13-05-2026

At Liberty Live Holdings, Inc.'s annual stockholder meeting on May 11, 2026, shareholders re-elected Bill Kurtz as a Class I director with strong support (43,078,052 votes for vs. 1,592,376 withheld). The selection of KPMG LLP as independent auditors for FY 2026 was ratified overwhelmingly (46,504,444 for vs. 14,187 against), and the say-on-pay proposal passed (40,534,072 for vs. 4,130,213 against), though with notable opposition; shareholders also approved holding future say-on-pay votes every three years (34,883,437 votes). All proposals received majority approval with minimal abstentions.

• · Broker non-votes: 1,904,130 across all proposals
• · Meeting held on May 11, 2026; Bill Kurtz to serve until 2029 annual meeting
• · Securities: Series A LLYVA and Series C LLYVK on Nasdaq

13-05-2026

D-Wave Quantum Inc. filed an 8-K on May 13, 2026, disclosing an error in its Form 10-Q for the quarter ended March 31, 2026. The 10-Q cover page incorrectly stated 366,737,601 shares of common stock outstanding as of May 11, 2026, with the correct number being 367,269,074 shares. Both figures exclude 3,176,096 exchangeable shares outstanding as of May 11, 2026.

13-05-2026

Asure Software, Inc. held its 2026 Annual Meeting of Stockholders on May 12, 2026, electing seven directors—Benjamin Allen, W. Carl Drew, Daniel Gill, Patrick Goepel, Grace Lee, Bradford Oberwager, and Bjorn Reynolds—with strong 'For' votes ranging from 20,681,969 to 22,960,093, though Patrick Goepel and Bjorn Reynolds saw higher withheld votes of 1,037,667 and 2,336,410 respectively. Stockholders ratified CBIZ CPAs PC as independent auditors for the year ending December 31, 2026, with 99.75% support (25,761,490 For vs. 18,419 Against and 46,384 Abstentions). 25,826,293 shares of common stock were represented at the meeting.

• · Director election votes - Benjamin Allen: 22,947,425 For, 70,954 Withheld
• · Director election votes - W. Carl Drew: 22,960,093 For, 58,286 Withheld
• · Director election votes - Daniel Gill: 22,942,922 For, 75,457 Withheld
• · Director election votes - Grace Lee: 22,204,325 For, 814,054 Withheld
• · Director election votes - Bradford Oberwager: 22,932,615 For, 85,764 Withheld

13-05-2026

On May 7, 2026, Kraft Heinz Foods Company, a wholly-owned subsidiary of The Kraft Heinz Company, entered into an underwriting agreement for the offering of €500,000,000 3.500% senior notes due 2031 and €500,000,000 3.950% senior notes due 2034 on a firm commitment basis with underwriters including Citigroup Global Markets Limited, Deutsche Bank AG London Branch, Goldman Sachs & Co. LLC, and Merrill Lynch International. The notes are expected to be issued on or around May 21, 2026, subject to customary closing conditions. No financial performance metrics or period comparisons were disclosed.

• · Underwriting agreement filed as Exhibit 1.1
• · Notes to be purchased on firm commitment basis
• · Issuer is 100% owned operating subsidiary of The Kraft Heinz Company

13-05-2026

Admiral Financial Corp reported zero interest income, total income, expenses, and net loss for the three and nine months ended March 31, 2026, identical to the prior year periods with no period-over-period changes. The balance sheet as of March 31, 2026, shows total assets of $0 (in thousands), total liabilities of $24 (in thousands), and stockholders' deficit of $24 (in thousands), unchanged from June 30, 2025. Cash flows from operating activities were $0 for the nine months ended March 31, 2026, matching the prior year, reflecting completely flat performance across all metrics.

• · Loss per share basic and diluted: $0.00 for all periods.
• · Preferred stock: none outstanding out of 6,000,000 authorized.
• · Common stock: $0.001 par value, 50,000,000 shares authorized.

13-05-2026

Dominari Holdings Inc. reported total revenue of $35,805 for the three months ended March 31, 2026, a 394% YoY increase from $7,240, primarily driven by underwriting services surging to $32,949 from $5,606 and new carried interest of $1,096. However, operating expenses rose 83% to $73,427 from $40,122, leading to a larger loss from operations of $37,622 (up 14% in magnitude) and net loss attributable to common stockholders of $57,358 versus $32,488 in Q1 2025. Operating cash flow swung to a use of $28,942 from a provision of $1,235, though cash and equivalents ended at $27,477.

• · Basic and diluted EPS of $(3.17) in Q1 2026 vs $(3.02) in Q1 2025.
• · Provision for income taxes of $12,868 in Q1 2026 vs $0 in Q1 2025.
• · Stock-based compensation for employees $19,243 in Q1 2026; advisors $36.
• · Cash dividends paid $9,971 in Q1 2026 vs $7,080 in Q1 2025.
• · Net cash provided by investing activities $32,123 in Q1 2026 vs used $5,436 in Q1 2025.

13-05-2026

Chenghe Acquisition III Co., a SPAC, reported net income of $884,748 for Q1 2026, driven by $1,061,505 in interest earned on its Trust Account, which grew to $128,931,590 from $127,870,085 at year-end 2025. However, the company incurred $176,757 in general and administrative costs, resulting in a net cash used in operating activities of $103,162 and a decline in cash to $593,663 from $696,825, while shareholders' deficit worsened to $(4,606,706) from $(4,429,949). Total assets increased slightly to $129,627,058 amid ongoing pre-acquisition operations.

• · Deferred underwriting fee remained at $5,060,000.
• · Entity is a shell company, emerging growth company, and small business filer.
• · Incorporated June 04, 2024 in Singapore.
• · Trading on NASDAQ under CHECU, CHEC, CHECW.

13-05-2026

SOLV Energy, Inc. reported Q1 2026 revenue of $676,805 thousand, up 66% YoY from $407,847 thousand, driven by New Construction services at 96.1% of total (up from 92.5%), with gross profit more than doubling to $119,073 thousand. However, SG&A expenses surged to $111,375 thousand (including $59,560 thousand non-cash compensation) from $36,070 thousand, resulting in an operating loss of $7,181 thousand versus a $9,261 thousand profit last year, and a net loss attributable to SOLV of $23,358 thousand. The company completed its IPO, raising $552,542 thousand net proceeds used to extinguish $405,203 thousand term debt, boosting total equity to $811,224 thousand.

• · Cash and cash equivalents decreased to $384,911 thousand from $394,876 thousand at Dec 31, 2025.
• · Total liabilities declined to $1,145,382 thousand from $1,361,047 thousand, primarily due to debt extinguishment.
• · Non-cash compensation expense in SG&A was $59,560 thousand in Q1 2026 vs $712 thousand in Q1 2025.
• · Amortization expense $14,879 thousand Q1 2026 vs $13,768 thousand Q1 2025.
• · Loss on debt extinguishment $10,688 thousand in Q1 2026.

13-05-2026

ASIAFIN HOLDINGS CORP. reported Q1 2026 revenue of $1,275,522, more than doubling YoY from $621,179, driven by strong growth across all segments: Fintech (+265%), RegTech (+42%), and RPA (+112%), achieving gross profit of $340,766 versus a prior-year loss of $6,913. However, net loss narrowed to $165,158 from $489,463 YoY amid higher SG&A expenses, while shareholders' equity declined to $2,409,253 from $2,566,166 QoQ and cash decreased slightly to $1,685,762.

• · Account receivables increased 12.6% QoQ to $1,245,284.
• · Contract liabilities rose 37.4% QoQ to $1,009,322.
• · SG&A expenses increased 4.8% YoY to $509,622.
• · Net cash used in operating activities improved slightly to $43,183 from $45,148 YoY.

13-05-2026

Armada Acquisition Corp. II reported net income of $1,131,313 for the three months ended March 31, 2026, driven by $2,105,061 in interest income from the Trust Account, compared to a $706 loss in the prior year period; however, general and administrative costs surged to $973,748 from $706, resulting in an operating loss of $973,748. For the six months ended March 31, 2026, net income was $527,553 versus a $46,490 loss prior year, supported by $4,406,950 in interest income, but operating losses widened to $3,879,397 amid rising expenses. The Trust Account grew to $239,035,116 from $234,628,166 at September 30, 2025, while cash declined 75.5% to $88,640 and accounts payable increased 255% to $4,982,190, with shareholders' deficit deepening to $14,023,966.

• · Basic and diluted EPS for Class A redeemable shares: $0.04 for three months ended March 31, 2026 and $0.02 for six months.
• · Accumulated deficit increased to $14,024,825 as of March 31, 2026 from $10,145,428 at September 30, 2025.
• · Total liabilities rose to $14,295,577 from $10,715,994 QoQ.
• · Company inception date: October 3, 2024.

13-05-2026

For Q1 FY2026, Hughes Satellite Systems Corp reported total revenue of $324,914, down 11.2% YoY from $366,064, with service revenue declining 10.2% to $249,491 and equipment sales dropping 14.7% to $75,423; however, total costs and expenses fell 24.2% to $308,053, resulting in operating income of $16,861 versus a prior-year loss of $40,187, and a narrower net loss of $7,679 (HSSC attributable: $7,309) compared to $49,040. Total assets decreased QoQ to $1,903,620 from $1,997,242, cash fell to $101,628 from $118,765, and stockholder's equity deficit worsened slightly to $856,511 from $852,617. The filing raises substantial doubt about the company's ability to continue as a going concern due to insufficient cash and financing for upcoming obligations.

• · Substantial doubt about going concern due to insufficient cash, projected cash flows, or committed financing for obligations over the next 12 months.
• · Current portion of debt and other notes payable: $1,510,174 as of March 31, 2026.
• · Trade accounts receivable net: $286,730 (March 31, 2026) vs $311,723 (Dec 31, 2025), allowance for credit losses $14,843 vs $17,559.

13-05-2026

Investcorp Credit Management BDC, Inc. (ICMB) reported total investment income of $3.55 million for Q1 2026, down 19% YoY from $4.37 million, with net investment income after taxes falling sharply to $0.19 million from $0.60 million due to higher net expenses and lower income components like PIK interest. The company posted a net decrease in net assets from operations of $8.63 million, driven by $8.83 million in unrealized depreciation on investments (vs. $3.23 million appreciation YoY), resulting in net assets declining 14% QoQ to $52.70 million and NAV per share dropping to $3.65 from $4.25. Total assets decreased 13% QoQ to $164.56 million amid a 12% reduction in investments to $151.42 million.

• · No stockholder distributions paid in Q1 2026 vs $0.12 per share in Q1 2025.
• · Debt refinanced: Issued $65M 2029 Notes, repaid $65M 2026 Notes and $14M on revolving facility.
• · Net cash provided by operating activities increased to $10.82M from $5.09M YoY.
• · Non-controlled, non-affiliated investments at fair value: $140.01M (265.68% of net assets) as of Mar 31, 2026.

13-05-2026

CIM Real Estate Finance Trust, Inc. reported net income of $43.1 million for Q1 2026, a significant turnaround from a $32.9 million loss in Q1 2025, driven by a $7.1 million decrease in provision for credit losses versus a $61.8 million increase prior year; however, total revenues declined 8% YoY to $97.6 million amid lower rental ($25.8M, -11%) and interest income ($71.8M, -7%). Total assets decreased QoQ to $4.73 billion from $5.10 billion, with loans held-for-investment net dropping to $3.09 billion from $3.45 billion, while stockholders' equity remained stable at $1.75 billion.

• · Distributions declared at $0.08 per common share in Q1 2026.
• · Weighted average common shares outstanding: 436,809,143 (basic and diluted) in Q1 2026.
• · Net cash provided by investing activities: $393.3 million in Q1 2026, driven by $483.8 million principal payments on loans.
• · EPS basic and diluted: $0.10 in Q1 2026 vs $(0.08) in Q1 2025.

13-05-2026

For Q1 2026, Black Rock Coffee Bar, Inc. reported total revenue of $55,454 up 24% YoY from $44,820, driven by store revenue growth to $55,384, with income from operations rising 19% to $2,676 and net income attributable to the company of $378. However, cash and cash equivalents fell 30% QoQ to $20,018 amid significant investing outflows of $16,525 primarily for property and equipment purchases of $16,209, despite operating cash flow improving to $6,791.

• · Tax receivable agreement liability increased to $42,527 from $38,893 QoQ.
• · Total shareholders' equity rose to $107,483 from $104,706 QoQ.
• · Weighted-average Class A shares outstanding: 17,562,299 basic and diluted.
• · Supplemental cash paid for interest: $323 (Q1 2026) vs $2,457 (Q1 2025).

13-05-2026

Gores Holdings X, Inc. reported net income of $6,147,078 for Q1 2026, a turnaround from a $54,039 net loss in Q1 2025, driven by $3,197,440 in interest income from the Trust Account and a $3,139,500 gain from the change in fair value of public warrant liabilities. However, net loss from operations widened to $189,862 from $54,039 YoY due to higher professional fees, cash balances declined QoQ to $431,326 from $619,576, and net cash used in operating activities was $188,250. The Trust Account grew QoQ to $370,939,623 from $367,742,183, while public warrants derivative liability decreased to $5,023,200 from $8,162,700.

• · Accumulated deficit improved to $(28,225,314) as of March 31, 2026 from $(31,302,452) as of December 31, 2025.
• · Total liabilities decreased to $29,233,641 from $32,376,841 QoQ.
• · Increase in redemption value of Class A ordinary shares subject to redemption charged $3,069,940 to accumulated deficit in Q1 2026.

13-05-2026

Vystar Corp reported Q1 2026 revenues of $6,147, a 51% YoY decline from $12,657, while gross profit remained nearly flat at $4,272 versus $4,307. Operating expenses fell 18% to $281,122, leading to a narrower net loss of $364,779 compared to $538,282 in Q1 2025, with cash balance rising to $9,907 from $4,454 at December 31, 2025. Total assets decreased to $438,027 from $452,450, and stockholders' deficit widened to $(6,900,522) from $(6,535,743).

• · Property and equipment, net declined to $1,441 from $12,139 QoQ.
• · Intangible assets, net decreased to $62,279 from $66,287 QoQ.
• · Inventories, net slightly declined to $57,609 from $58,912 QoQ.
• · Net cash used in operating activities improved to $(41,047) from $(86,042) YoY.

13-05-2026

Dune Acquisition Corp II (ticker IPODU), a SPAC, reported net income of $714,594 for the three months ended March 31, 2026, versus a $48,094 loss in Q1 2025, driven by $1,300,569 in interest income from the Trust Account while operating loss widened significantly to $585,975 from $48,094. The Trust Account grew to $149,211,344 from $147,910,775 QoQ, but cash declined sharply to $84,207 from $365,751 and shareholders' deficit increased to $(6,046,436) from $(5,460,461). Basic and diluted EPS for non-redeemable shares was $0.04, up from $(0.01) YoY.

• · Total liabilities increased to $6,258,003 from $5,847,477 QoQ.
• · Deferred legal fees of $366,068 recognized in Q1 2026.
• · Entity is a shell company, emerging growth company, and small business.
• · Class A ordinary shares redemption value $10.38 per share at March 31, 2026 (up from $10.29 at Dec 31, 2025).

13-05-2026

For Q1 2026, Firefly Neuroscience reported revenue of $485 thousand, up over 1,028% YoY from $43 thousand, with gross profit rising to $221 thousand from $43 thousand, and net loss narrowing significantly to $2,004 thousand from $12,930 thousand. However, operating expenses increased 6% YoY to $2,231 thousand, leading to an ongoing operating loss of $2,010 thousand, while cash used in operations improved slightly to $1,948 thousand from $2,511 thousand. Balance sheet shows total assets at $10,910 thousand (up QoQ from $10,477 thousand), cash at $3,127 thousand, and shareholders' equity up to $8,442 thousand.

• · Common shares outstanding increased to 14,865,356 at March 31, 2026 from 13,964,367 at December 31, 2025.
• · Private placement net proceeds $2,236 thousand in Q1 2026.
• · Accumulated deficit grew to $113,619 thousand at March 31, 2026 from $111,615 thousand at December 31, 2025.

13-05-2026

Belpointe PREP, LLC reported Q1 2026 revenue of $4,235, a 143.5% YoY increase from $1,739, primarily from higher rental revenue. However, the net loss attributable to the company widened to $10,665 from $8,619 YoY (23.7% increase in loss magnitude), driven by elevated property expenses ($5,002, +85.1% YoY), interest expense ($5,285, +21.3% YoY), and depreciation ($3,077, +60.5% YoY). Balance sheet showed slight total assets growth to $565,742 QoQ (+0.3%), but cash declined to $19,568 (-19.6% QoQ) and Class A members’ capital fell to $265,486 (-2.7% QoQ).

• · Net cash used in operating activities improved slightly to $6,106 in Q1 2026 from $6,618 YoY (-7.7%).
• · Net cash used in investing activities decreased to $15,266 from $20,629 YoY (-26.0%), with lower real estate development spend.
• · Net cash provided by financing activities fell to $15,966 from $25,922 YoY (-38.4%).
• · Loss per Class A unit worsened to $(2.75) from $(2.35) YoY.
• · Weighted-average Class A units outstanding increased to 3,879,246 from 3,666,000 YoY.

13-05-2026

Spectral AI reported Q1 2026 research and development revenue of $3,991 thousand, down 40% YoY from $6,707 thousand, driven by a 48% drop in BARDA funding to $3,311 thousand despite a 109% increase in other U.S. governmental revenue to $680 thousand. The company swung to a net loss of $3,412 thousand from a $2,897 thousand profit in Q1 2025, with operating loss widening to $1,971 thousand and cash used in operations rising to $3,728 thousand; cash balance declined to $11,655 thousand from $15,394 thousand at year-end 2025. Total assets fell to $17,734 thousand from $21,405 thousand, while stockholders' deficit deepened to $8,810 thousand.

• · General and administrative expenses slightly declined to $3,998 thousand from $4,064 thousand YoY.
• · Warrant liabilities increased to $12,535 thousand from $11,533 thousand QoQ.
• · Notes payable current increased to $3,912 thousand from $2,854 thousand QoQ.
• · Stockholders’ deficit worsened to $(8,810) thousand from $(5,727) thousand QoQ.

13-05-2026

Franklin Crypto Trust's net assets increased 1.6% QoQ to $10,380,648 at March 31, 2026 from $10,215,391 at December 31, 2025, supported by $2,629,480 in proceeds from share issuances which boosted shares outstanding 33% to 600,000. However, NAV per share declined 24% to $17.30 from $22.70 amid a net decrease in net assets from operations of $2,464,223, driven by $2,436,041 unrealized depreciation and $23,634 realized losses on digital assets. Investments in digital assets rose slightly 1.6% to $10,382,311, with Bitcoin value up 3.9% but Ether down 7.1%.

• · Sponsor's fee expense of $4,548 for Q1 2026.
• · Net cash from operating activities $(2,629,480); fully offset by financing inflows.
• · Bitcoin sales to pay expenses: 0.0450 BTC principal value $3,314.
• · Ether rebalancing sales: 8.6490 ETH for $17,592.

13-05-2026

SenesTech, Inc. reported Q1 2026 net revenues of $493 thousand, up 1.6% YoY from $485 thousand, with gross profit rising 8.0% to $338 thousand. However, total operating expenses increased 24.3% to $2,457 thousand, driven by a 30.6% surge in selling, general, and administrative expenses to $2,035 thousand, resulting in a wider net loss of $2,063 thousand versus $1,665 thousand in Q1 2025. Cash and cash equivalents declined 10.2% QoQ to $6,804 thousand from $7,575 thousand at December 31, 2025, amid $1,929 thousand net cash used in operations.

• · Weighted average shares outstanding increased to 5,263,717 in Q1 2026 from 1,299,971 in Q1 2025.
• · Net cash used in operating activities worsened to $1,929 thousand from $1,557 thousand YoY.
• · Proceeds from issuances of common stock, net: $173 thousand in Q1 2026 vs $1,066 thousand in Q1 2025.

13-05-2026

Mivtachim The Workers Social Insurance Fund Ltd. (Under Special Management) filed Form 13F-HR on May 13, 2026, reporting U.S. equity holdings as of March 31, 2026, on behalf of itself and affiliated Israeli pension/provident funds including Kerren Makefet Pension and Provident Center and Keren Hgimlaot Hmerkazit Histradrut Central Pension Fund, plus a portion of Karnit Road Accident Victims Compensation Fund. Key holdings include Tower Semiconductor Ltd. ($47413819), Select Sector SPDR Trust Technology ETF ($40707536), Teva Pharmaceutical Industries Ltd. Sponsored ADS ($33940481), Nova Ltd. ($31642075), and SPDR S&P 500 ETF Trust ($24668047). The portfolio emphasizes semiconductors, technology ETFs, and Israeli-related firms, with all voting authority reported as sole or defined by other managers.

• · Aggregates holdings from multiple funds not individually required to file 13F
• · Business address: 125 Menachem Begin Street, Tel Aviv, L3 67021
• · No shared voting authority reported (all sole or DFND with 0 shared/none)

13-05-2026

Commonwealth Bank of Australia filed a 13F-HR report on May 13, 2026, disclosing its U.S. equity holdings as of March 31, 2026. The portfolio includes $227860706 in Klarna Group PLC SHS (17407235 shares held solely) and $3157135 in GEMINI SPACE STA INC CL A COM (714284 shares held solely). No prior period comparisons or performance changes are provided in the filing.

• · CUSIP for GEMINI SPACE STA INC CL A COM: 36866J105
• · CUSIP for KLARNA GROUP PLC SHS: G5279N105
• · Report filed under SEC file number 028-14376

13-05-2026

Zenas BioPharma reported Q1 2026 financial results with cash, cash equivalents, and investments of $718.5 million, bolstered by $419.0 million in gross proceeds from financings extending runway into Q2 2029, and positive Phase 3 INDIGO trial results for obexelimab demonstrating a 56% reduction in IgG4-RD flare risk. However, R&D expenses increased 73% YoY to $60.4 million, G&A expenses rose 36% to $16.9 million, and net loss widened to $81.0 million from $33.6 million due to higher clinical, manufacturing, and personnel costs. Corporate progress includes completed enrollment in the Phase 2 SunStone SLE trial with topline data expected Q4 2026 and first dosing in ZB021 Phase 1 trial.

• · Obexelimab BLA submission to FDA targeted for Q2 2026; MAA to EMA in H2 2026
• · INDIGO trial data oral presentation at EULAR 2026 Congress on June 4, 2026
• · ZB021 Phase 1 initial data expected year-end 2026; POC trial in psoriasis planned for 2027
• · ZB022 and ZB014 Phase 1 studies expected in 2027 subject to oIND results
• · $45.0 million aggregate gross proceeds from underwriters’ full exercise of over-allotment options
• · Potential $75 million milestone from Royalty Pharma and $75 million debt draw upon FDA approval of obexelimab for IgG4-RD